Modeling the impact of case finding for tuberculosis: The role of infection dynamics
Theresa S Ryckman1, Sourya Shrestha2, Anthony T Fojo3
1Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland 21287.
Abstract:
Population-level case-finding is globally recommended as a strategy to reduce the burden of tuberculosis in high-burden settings, but mathematical models overwhelmingly project that case-finding will yield only modest reductions in incidence. We evaluated whether the common assumption of lifelong risk of progression after infection leads models to undervalue the impact of case-finding. Specifically, clearance of latent infection reduces the rate of long-term "reactivation", which could result in more pronounced effects from interventions (such as case-finding) that reduce M. tuberculosis transmission. To investigate this possibility, we constructed two models - one assuming lifelong progression risk after infection ("Conventional"), and one assuming that some individuals clear their infections ("Clearance"). We calibrated these models to empirical data on tuberculosis burden in India and progression after infection. We used the calibrated models to project the impact of community-wide active case-finding campaigns covering 75% of the population every two years, with or without mass provision of tuberculosis preventive treatment (TPT). Relative to the Conventional model, the posterior distributions of Clearance model outputs were more similar to empirical estimates of disease incidence, infection prevalence, progression over time, and incidence trends, demonstrating better fit. The Clearance model also projected a greater impact of case-finding on incidence: 26% [95% uncertainty interval: 15-41%] vs. 11% [7-24%] reduction after 10 years. Given that clearance of some infections is biologically likely and results in better model fit, we conclude that the epidemiological impact of population-level case-finding for tuberculosis may be greater than that projected by models that exclude this effect.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Steps in Outbreak Investigation
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
